Trial Profile
Phase II proof of concept trial of MDGN 201 in patient with renal impairment.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 12 Aug 2015
Price :
$35
*
At a glance
- Drugs MDGN 201 (Primary)
- Indications Renal impairment
- Focus Proof of concept; Therapeutic Use
- Sponsors Aevi Genomic Medicine
- 12 Aug 2015 New trial record